BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3931212)

  • 1. Acquired resistance to auranofin in cultured human cells.
    Glennås A; Rugstad HE
    Scand J Rheumatol; 1985; 14(3):230-8. PubMed ID: 3931212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metallothionein in cultured human epithelial cells and synovial rheumatoid fibroblasts after in vitro treatment with auranofin.
    Glennås A; Hunziker PE; Garvey JS; Kägi JH; Rugstad HE
    Biochem Pharmacol; 1986 Jun; 35(12):2033-40. PubMed ID: 3087367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gold resistance in cultured human cells possible role of metallothionein.
    Glennås A
    Scand J Rheumatol Suppl; 1983; 51():42-4. PubMed ID: 6426052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cultured human cells with high levels of gold-binding cytosolic metallothionein are not resistant to the growth inhibitory effect of sodium aurothiomalate.
    Glennås A; Rugstad HE
    Ann Rheum Dis; 1986 Feb; 45(2):101-9. PubMed ID: 3080971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ploidity and cell cycle progression during treatment with gold chloride, auranofin and sodium aurothiomalate. Studies on a human epithelial cell line and its sub-strains made resistant to the antiproliferative effects of these gold compounds.
    Glennås A; Rugstad HE
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1985; 49(4):385-93. PubMed ID: 2867637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Partial cross-resistance between auranofin and sodium aurothiomalate in cultured human cells.
    Rugstad HE; Glennås A
    Scand J Rheumatol; 1988; 17(3):175-81. PubMed ID: 3140371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Auranofin treatment of rats: adaptation to intestinal adverse effects and observations on the cytosolic distribution of gold in the intestines, liver and kidneys.
    Glennås A
    Acta Pharmacol Toxicol (Copenh); 1985 May; 56(5):404-9. PubMed ID: 3929564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cultured human cells with a high content of metallothionein show resistance against gold-chloride.
    Glennås A; Bakka A; Rugstad HE
    Scand J Rheumatol; 1983; 12(4):321-4. PubMed ID: 6658395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acquired resistance against gold(III)-chloride in cultured human cells.
    Glennås A; Rugstad HE
    Scand J Rheumatol; 1985; 14(1):25-32. PubMed ID: 4001875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of metallothionein gene expression in mammalian cells by gold compounds.
    Butt TR; Sternberg EJ; Mirabelli CK; Crooke ST
    Mol Pharmacol; 1986 Feb; 29(2):204-10. PubMed ID: 3081791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cultured human cells can acquire resistance to the antiproliferative effect of sodium aurothiomalate.
    Glennås A; Rugstad HE
    Ann Rheum Dis; 1986 May; 45(5):389-95. PubMed ID: 3087299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of human immune responsiveness in vitro by auranofin.
    Salmeron G; Lipsky PE
    J Rheumatol Suppl; 1982; 8():25-31. PubMed ID: 6813487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of metallothionein is correlated with resistance to auranofin, a gold compound, in Chinese hamster ovary cells.
    Monia BP; Butt TR; Mirabelli CK; Ecker DJ; Sternberg E; Crooke ST
    Mol Pharmacol; 1987 Jan; 31(1):21-6. PubMed ID: 3807890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative pharmacokinetics of triethylphosphine gold (auranofin) and gold sodium thiomalate (GST).
    Furst DE; Dromgoole SH
    Clin Rheumatol; 1984 Mar; 3 Suppl 1():17-24. PubMed ID: 6432409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mechanisms of action of auranofin and other gold complexes as related to their biologic activities.
    Crooke ST; Mirabelli CK
    Am J Med; 1983 Dec; 75(6A):109-13. PubMed ID: 6419591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of action of auranofin: effects on humoral immune response.
    Walz DT; Dimartino MJ; Griswold DE
    J Rheumatol Suppl; 1982; 8():32-6. PubMed ID: 6813489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies of the effect of auranofin, a new antiarthritic agent, on platelet aggregation.
    Nathan I; Finkelstein AE; Walz DT; Dvilansky A
    Inflammation; 1982 Mar; 6(1):79-85. PubMed ID: 6806182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular association, intracellular distribution, and efflux of auranofin via sequential ligand exchange reactions.
    Snyder RM; Mirabelli CK; Crooke ST
    Biochem Pharmacol; 1986 Mar; 35(6):923-32. PubMed ID: 3082334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution of gold in rat blood after intravenous administration of auranofin, gold sodium thiomalate and aurothioglucose to rats.
    Walz DT; Griswold DE; DiMartino MJ; Bumbier EE
    J Rheumatol; 1983 Feb; 10(1):117-20. PubMed ID: 6405031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress in the characterization of gold drugs.
    Grootveld MC; Razi MT; Sadler PJ
    Clin Rheumatol; 1984 Mar; 3 Suppl 1():5-16. PubMed ID: 6432413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.